Skip to main content
OpenTrials

Clinical trial condition

Mycosis Fungoides

Explore clinical trials studying Mycosis Fungoides. Study availability and eligibility vary by location and protocol.

307 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Mycosis Fungoides trial results

Completed

Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin

NCT00066664

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Stanford Cancer Center Stanford, California, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00020579

Conditions
AIDS-related Kaposi sarcoma, Adenocarcinoma, Adenoma, +214 more
Locations
  • National Naval Medical Center Bethesda, Maryland, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • NCI - Center for Cancer Research Bethesda, Maryland, United States
View Trial Details
Completed

Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma

NCT00589381

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +48 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale, Florida, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
View Trial Details
Completed

Forodesine in the Treatment of Cutaneous T-Cell Lymphoma

NCT00501735

Conditions
Cutaneous T-cell Lymphoma (CTCL),, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • University of Alabama at Birmingham, Comprehensive Cancer Ctr Birmingham, Alabama, United States
  • Stanford University Medical Center Stanford, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 41 locations
View Trial Details

Related conditions